Insulet | PODD - Trade Creditors

Stock Price
251.24
Daily Change
0.02 0.01%
Monthly
-11.38%
Yearly
-11.75%
Q1 Forecast
247.93

Insulet reported $48.2M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Abbott USD 4.12B 183M Sep/2025
Align Technology USD 125.55M 11.12M Sep/2025
AtriCure USD 74.84M 8.91M Sep/2025
Avanos Medical USD 54.2M 5.4M Sep/2025
Baxter International USD 953M 42M Sep/2025
Becton, Dickinson and Co. USD 1.97B 4.38B Sep/2025
Boston Scientific USD 1B 40M Sep/2025
Cardinal Health USD 36.86B 2.15B Sep/2025
Cooper Companies USD 300.4M 44.5M Sep/2025
Dexcom USD 451.5M 20.5M Sep/2025
Edwards Lifesciences USD 165M 94.2M Sep/2025
Eli Lilly USD 4.26B 186.5M Sep/2025
Globus Medical USD 87.23M 128K Sep/2025
ICU Medical USD 171.75M 2.93M Sep/2025
Insulet USD 48.2M 47.9M Sep/2025
Integra LifeSciences USD 92.3M 530K Sep/2025
J&J USD 9.62B 161M Sep/2025
Masimo USD 117.9M 17.8M Sep/2025
Medtronic USD 2.56B 106M Jun/2025
Merit Medical Systems USD 64.75M 4.32M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Solventum Corp USD 669M 26M Sep/2025
Stryker USD 1.5B 56M Sep/2025
Tandem Diabetes Care USD 47.48M 8.36M Sep/2025
Teleflex USD 165.91M 8.35M Sep/2025
West Pharmaceutical Services USD 255.8M 16.8M Sep/2025
Zimmer Biomet Holdings USD 315.3M 33.4M Sep/2025